Analyst: Infuse fallout could lead to Medtronic selling spine biz

A Wall Street analyst has speculated that Medtronic's woes over its blockbuster Infuse product might lead the medical device company to pull the plug on the entire spinal business. News

Suggested Articles

Spinal Elements, maker of a wide range of implants and products for minimally invasive spine procedures, has filed a $100 million IPO.

United Airlines will begin providing COVID-19 screening tests for passengers, allowing those who test negative to skip local quarantine requirements.

Babson Diagnostics has closed its series A funding round with a total of $13.7 million and named a new CEO.